It has been confirmed by a study that downregulated FDFT1 is related to late tumor progression and worse prognosis in CRC, and FDFT1 suppresses the tumorigenesis through negative regulation of AKT/mTOR/HIF1α signaling pathway (Weng et al., 2020). This evidence concerns the gene FDFT1 and colorectal carcinoma.